The press release from Valneva suggests their inactivated COVID-19 vaccine candidate was shown to neutralize the Omicron variant of SARS-CoV-2.
Dr Clive Dix, former Chair of the UK Vaccine Taskforce, said:
“This is very encouraging data and adds to the positive Phase 3 data. Hopefully this vaccine will be approved soon and should become an important vaccine in both this pandemic in countries still behind the curve and as a vaccine for boosting during the winter of 2022/23.”
All our previous output on this subject can be seen at this weblink:
Dr Clive Dix: “No conflicts.”